Frank Holz

About Frank Holz

Frank Holz is an AMD researcher whose focus is on the pathogenesis and therapy of AMD as well as on retinal imaging methodologies and phenotyping.  In addition, Holz has lead numerous ranibizumab clinical trials. He is Editor-in-Chief of the journal of the German Ophthalmological Society (DOG), Der Ophthalmologe, and a past president of DOG.